| Name |
Research Interests |
| Michael
Apicella, M.D. |
Molecular basis of the human immune response
to pathogenic Neisseria and Haemophilus; Neisseria and Haemophilus
vaccine technology. |
| Robert Ashman,
M.D. |
B lymphocyte activation and programmed
death. |
| Zuhair Ballas,
M.D. |
Thymic ontogeny; Killer cells; Immunodeficiency.
|
| Gail Bishop,
Ph.D. |
Molecular basis of B cell signaling; Structure-function
analysis of signal receptors. |
| John Butler,
Ph.D. |
Antibody repertoire development; Mucosal
Immunity. |
| John Cowdery,
M.D. |
T cell regulation of B cell responses;
Anti-T cell immunotherapy. |
| Morris Dailey,
M.D.,Ph.D. |
Intercellular recognition and adhesion
receptors; T cell differentiation; Effector T cells and inflammation.
|
| Elizabeth Field,
M.D. |
Transplant immunology; T helper cell subsets;
T cell tolerance. |
| Thomas Griffith,
Ph.D. |
My research is focused on identifying methods
of using apoptotic cell death in the treatment of cancer. |
| John Harty,
Ph.D. |
Specificity and effector mechanisms in
CD8+ T cell immunity to bacterial infection. |
| Jonathan
Heusel, M.D., Ph.D. |
The mechanisms of activation of natural
killer (NK) cells and the interactions between NK cells and dendritic
cells in the settings of viral infection and allogeneic hematopoietic
stem cell transplantation. |
| Bruce
Hostager, Ph.D. |
Signal transduction in cells
of the immune system, focusing on TNF receptor family members. |
| Joel
Kline , M.D. |
Study of the modulation of airway
inflammatory responses in asthma. |
| Michael
Knudson, M.D., Ph.D |
Understanding the Regulation
of Programmed Cell Death. |
| David Kusner,
M.D.,Ph.D. |
Innate immunity, Signal transduction in
macrophages, Tuberculosis |
| David Lubaroff,
Ph.D. |
Lymphocyte effector populations; Lymphocyte
Activation; Tumor immunology. |
| Richard Lynch,
M.D. |
Structure and function of IgA, IgM, and
IgE Fc receptors; Tumor immunology. |
| Brian Martin,
Ph.D. |
We study the role of inflammatory complement
proteins in cell signaling, chemotaxis and cancer growth control. |
| Craig Morita,
M.D.,Ph.D. |
Human gd T cell recognition of nonpeptide
antigens and CD1. |
| William Nauseef,
M.D. |
Neutrophil structure and function; Neutrophil
signaling pathways. |
| Stanley Perlman,
M.D.,Ph.D. |
Pathogenesis of demyelination caused by
viral infection of the CNS; mechanisms of brain inflammation. |
| Frederick
Quelle, Ph.D. |
Cytokine receptor signal transduction mechanisms
regulating the growth, survival, and function of blood cells |
| Timothy Ratliff,
Ph.D. |
Host immune response to tumors. |
| Thomas
Waldschmidt, Ph.D. |
B lymphocyte biology; T cell-B
cell interactions; Autoimmune disease. |
| George Weiner,
M.D. |
Immune response to lymphoma; Bispecific
therapeutic antibodies. |
| Joel Weinstock,
M.D. |
Role of T cell subsets and cytokines in
granulomatous inflammation; Immune response to Schistosome infection.
|
| Jerrold Weiss,
Ph.D. |
Inflammatory Response to Invading Bacteria
|
| Mary Wilson,
M.D. |
Pathogenisis of infection with the parasite,
Leishmania chagasi. |
